ÂÌñ»»ÆÞ

Coming from our latest issue, Editor-in-Chief Malena Garcia examines how AI-driven protein design is revolutionizing antivenom development. By replacing traditional, animal-derived methods with synthetic binders, this approach offers faster, more effective, and thermally stable treatments for snakebite envenoming, a historically long-neglected global health threat.

Writer Aidan Magruder critically examines how advancements in genetic engineering are reviving plants as pharmaceutical factories. By overcoming challenges in DNA transfection, selective breeding, and stable compound production, researchers are developing sustainable, plant-based alternatives to conventional drug synthesis. From anti-cancer compounds to bioengineered heparin, this approach offers an eco-friendly and accessible path to next-generation medicine.

"The CEM Staff Daily" offers a snapshot into the daily operations, insights, and achievements of the CEM team. From project highlights and staff milestones to behind-the-scenes updates, this article captures the pulse of a dynamic workplace committed to collaboration, innovation, and excellence.